Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Breast Cancer

Free Subscription Articles published in Clin Breast Cancer Retrieve available abstracts of 247 articles: HTML format Text format

Single Articles

July 2019
1. TOSS A, Venturelli M, Sperduti I, Molinaro E, et al
   First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysis.
   Clin Breast Cancer. 2019 Jul 24. pii: S1526-8209(19)30418.
   PubMed     Text format     Abstract available
   
   
   
2. CANTINI L, Pistelli M, Merloni F, Fontana A, et al
   Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.
   Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(19)30081.
   PubMed     Text format     Abstract available
   
   
   
3. DONG J, Esham KS, Boehm L, Karim SA, et al
   Timeliness of Treatment Initiation in Newly Diagnosed Patients With Breast Cancer.
   Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(18)30831.
   PubMed     Text format     Abstract available
   
   
   June 2019
4. CATTELL RF, Kang JJ, Ren T, Huang PB, et al
   MRI Volume Changes of Axillary Lymph Nodes as Predictor of Pathologic Complete Responses to Neoadjuvant Chemotherapy in Breast Cancer.
   Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30037.
   PubMed     Text format     Abstract available
   
   
   
5. FERREIRA AR, Ribeiro J, Miranda A, Mayer A, et al
   Effectiveness of Adjuvant Ovarian Function Suppression in Premenopausal Women With Early Breast Cancer: A Multicenter Cohort Study.
   Clin Breast Cancer. 2019 Jun 26. pii: S1526-8209(19)30263.
   PubMed     Text format     Abstract available
   
   
   
6. PATHAK M, Dwivedi SN, Deo SVS, Thakur B, et al
   Effectiveness of Added Targeted Therapies to Neoadjuvant Chemotherapy for Breast Cancer: A Systematic Review and Meta-analysis.
   Clin Breast Cancer. 2019 Jun 20. pii: S1526-8209(19)30323.
   PubMed     Text format     Abstract available
   
   
   
7. LEVASSEUR N, Willemsma KA, Li H, Gondara L, et al
   Efficacy of Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in ER-positive Breast Cancer: Results From a Prospective Institutional Database.
   Clin Breast Cancer. 2019 Jun 11. pii: S1526-8209(19)30033.
   PubMed     Text format     Abstract available
   
   
   
8. ROSSI L, McCartney A, Risi E, De Santo I, et al
   Cyclin-Dependent Kinase 4/6 Inhibitors in Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer.
   Clin Breast Cancer. 2019 Jun 11. pii: S1526-8209(19)30307.
   PubMed     Text format     Abstract available
   
   
   
9. LIVINGSTON-ROSANOFF D, Schumacher J, Vande Walle K, Stankowski-Drengler T, et al
   Does Tumor Size Predict Response to Neoadjuvant Chemotherapy in the Modern Era of Biologically Driven Treatment? A Nationwide Study of US Breast Cancer Patients.
   Clin Breast Cancer. 2019 Jun 6. pii: S1526-8209(19)30303.
   PubMed     Text format     Abstract available
   
   
   
10. FARES J, Kanojia D, Rashidi A, Ahmed AU, et al
    Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations.
    Clin Breast Cancer. 2019 Jun 5. pii: S1526-8209(19)30262.
    PubMed     Text format     Abstract available
    
    
    
11. BOEHM L, Weisberg T, Linendoll N, Damon AC, et al
    Development of Phase-Specific Breast Cancer Survivorship Care Plans.
    Clin Breast Cancer. 2019 Jun 5. pii: S1526-8209(19)30138.
    PubMed     Text format     Abstract available
    
    
    May 2019
12. VAHEDNIA E, Shandiz FH, Bagherabad MB, Moezzi A, et al
    The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
    Clin Breast Cancer. 2019 May 31. pii: S1526-8209(18)30646.
    PubMed     Text format     Abstract available
    
    
    
13. GOEL S, Pernas S, Tan-Wasielewski Z, Barry WT, et al
    Ribociclib Plus Trastuzumab in Advanced HER2-Positive Breast Cancer: Results of a Phase 1b/2 Trial.
    Clin Breast Cancer. 2019 May 30. pii: S1526-8209(19)30313.
    PubMed     Text format     Abstract available
    
    
    
14. LI H, Chen Y, Wang X, Tang L, et al
    T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis.
    Clin Breast Cancer. 2019 May 30. pii: S1526-8209(19)30316.
    PubMed     Text format     Abstract available
    
    
    
15. LAFRENIE RM, Speigl L, Buckner CA, Pawelec G, et al
    Frequency of Immune Cell Subtypes in Peripheral Blood Correlates With Outcome for Patients With Metastatic Breast Cancer Treated With High-Dose Chemotherapy.
    Clin Breast Cancer. 2019 May 27. pii: S1526-8209(19)30015.
    PubMed     Text format     Abstract available
    
    
    
16. DREHER N, Hadeler EK, Hartman SJ, Wong EC, et al
    Fitbit Usage in Patients With Breast Cancer Undergoing Chemotherapy.
    Clin Breast Cancer. 2019 May 25. pii: S1526-8209(19)30229.
    PubMed     Text format     Abstract available
    
    
    
17. HARPER NW, Hodges KB, Stewart RL, Wu J, et al
    Adjuvant Treatment of Triple-Negative Metaplastic Breast Cancer With Weekly Paclitaxel and Platinum Chemotherapy: Retrospective Case Review From a Single Institution.
    Clin Breast Cancer. 2019 May 24. pii: S1526-8209(19)30123.
    PubMed     Text format    
    
    
    
18. PARK G, Bae K, Hwang IY, Kim JS, et al
    Prediction of Residual Malignancy After Excisional Biopsy for Breast Cancer With Suspicious Microcalcifications: Comparison of Mammography and Magnetic Resonance Imaging.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30289.
    PubMed     Text format     Abstract available
    
    
    
19. CHOW S, Wan BA, Pidduck W, Zhang L, et al
    Symptoms Predictive of Overall Quality of Life Using the Edmonton Symptom Assessment Scale in Breast Cancer Patients Receiving Radiotherapy.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30055.
    PubMed     Text format     Abstract available
    
    
    
20. FARRA C, Fedda F, Tfayli A, Tawil A, et al
    The Impact of Partial Weak Staining in Normal Breast Epithelium on the Reliability of Immunohistochemistry Results in HercepTest-positive Breast Cancer.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(18)30847.
    PubMed     Text format     Abstract available
    
    
    
21. GORI S, Puglisi F, Moroso S, Fabi A, et al
    The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30011.
    PubMed     Text format     Abstract available
    
    
    
22. ZHOU Y, Simmons J, Jordan CD, Sonbol MB, et al
    Aspirin Treatment Effect and Association with PIK3CA Mutation in Breast Cancer: A Biomarker Analysis.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30066.
    PubMed     Text format     Abstract available
    
    
    
23. GAO F, Ge R
    LOC643714 Polymorphisms Contribute to an Elevated Susceptibility to Breast Cancer: A Meta-analysis of 231,191 Subjects.
    Clin Breast Cancer. 2019 May 18. pii: S1526-8209(19)30241.
    PubMed     Text format     Abstract available
    
    
    
24. STUEBER TN, Wischnewsky M, Leinert E, Diessner J, et al
    B(2) Prognostic Score: External Validation of a Clinical Decision-making Tool for Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 May 3. pii: S1526-8209(18)30867.
    PubMed     Text format     Abstract available
    
    
    
25. UPSHAW JN, Ruthazer R, Miller KD, Parsons SK, et al
    Personalized Decision Making in Early Stage Breast Cancer: Applying Clinical Prediction Models for Anthracycline Cardiotoxicity and Breast Cancer Mortality Demonstrates Substantial Heterogeneity of Benefit-Harm Trade-off.
    Clin Breast Cancer. 2019 May 2. pii: S1526-8209(18)30571.
    PubMed     Text format     Abstract available
    
    
    April 2019
26. JHA S, Wyld L, Krishnaswamy PH
    The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Apr 19. pii: S1526-8209(19)30078.
    PubMed     Text format     Abstract available
    
    
    
27. XU L, Zhang Z, Xiang Q, Liu Q, et al
    Extended Adjuvant Therapy With Aromatase Inhibitors for Early Breast Cancer: A Meta-analysis of Randomized Controlled Trials.
    Clin Breast Cancer. 2019 Apr 19. pii: S1526-8209(18)30531.
    PubMed     Text format     Abstract available
    
    
    
28. BRUFSKY A, Mitra D, Davis KL, Nagar SP, et al
    Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR(-)/HER2(-) Advanced Breast Cancer Enrolled in an Expanded Access Program.
    Clin Breast Cancer. 2019 Apr 18. pii: S1526-8209(18)30809.
    PubMed     Text format     Abstract available
    
    
    
29. MRUGALA MM, Kim B, Sharma A, Johnson N, et al
    Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.
    Clin Breast Cancer. 2019 Apr 18. pii: S1526-8209(19)30099.
    PubMed     Text format     Abstract available
    
    
    
30. GORNES H, Cabarrou B, Jouve E, Franchet C, et al
    Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer.
    Clin Breast Cancer. 2019 Apr 17. pii: S1526-8209(19)30018.
    PubMed     Text format     Abstract available
    
    
    
31. LI Y, Cui X, Yang YJ, Chen QQ, et al
    Serum sPD-1 and sPD-L1 as Biomarkers for Evaluating the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients.
    Clin Breast Cancer. 2019 Apr 11. pii: S1526-8209(18)30653.
    PubMed     Text format     Abstract available
    
    
    
32. TIAINEN L, Hamalainen M, Luukkaala T, Tanner M, et al
    Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Apr 4. pii: S1526-8209(18)30840.
    PubMed     Text format     Abstract available
    
    
    March 2019
33. NAMURA M, Tsunoda H, Kobayashi D, Enokido K, et al
    The Loss of Lymph Node Metastases After Neoadjuvant Chemotherapy in Patients With Cytology-proven Axillary Node-positive Primary Breast Cancer.
    Clin Breast Cancer. 2019 Mar 11. pii: S1526-8209(18)30858.
    PubMed     Text format     Abstract available
    
    
    
34. SILVER E, Wenger N, Xie Z, Elashoff D, et al
    Implementing a Population-Based Breast Cancer Risk Assessment Program.
    Clin Breast Cancer. 2019 Mar 11. pii: S1526-8209(18)30761.
    PubMed     Text format     Abstract available
    
    
    
35. NUGENT BD, Ren D, Bender CM, Rosenzweig M, et al
    The Impact of Age and Adjuvant Chemotherapy Modifications on Survival Among Black Women With Breast Cancer.
    Clin Breast Cancer. 2019 Mar 7. pii: S1526-8209(18)30643.
    PubMed     Text format     Abstract available
    
    
    
36. LARSEN V, Barlow WE, Yang JJ, Zhu Q, et al
    Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
    Clin Breast Cancer. 2019 Mar 6. pii: S1526-8209(18)30783.
    PubMed     Text format     Abstract available
    
    
    
37. ALTUNDAG K
    Characteristics of Patients With Breast Cancer With Brain Metastases Who Live Longer Than 60 Months.
    Clin Breast Cancer. 2019 Mar 6. pii: S1526-8209(19)30105.
    PubMed     Text format    
    
    
    February 2019
38. WOODWARD N, De Boer RH, Redfern A, White M, et al
    Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE).
    Clin Breast Cancer. 2019 Feb 27. pii: S1526-8209(18)30696.
    PubMed     Text format     Abstract available
    
    
    
39. LANDERCASPER J, Ramirez LD, Borgert AJ, Ahmad HF, et al
    A Reappraisal of the Comparative Effectiveness of Lumpectomy Versus Mastectomy on Breast Cancer Survival: A Propensity Score-Matched Update From the National Cancer Data Base (NCDB).
    Clin Breast Cancer. 2019 Feb 21. pii: S1526-8209(18)30861.
    PubMed     Text format     Abstract available
    
    
    
40. MATRAI Z, Ujhelyi M, Kovacs T, Kelemen P, et al
    Evaluation of a Retroglandular Oncoplastic Technique as a Standard Level I Oncoplastic Breast-Conserving Surgery: A Retrospective Clinicopathologic Study of 102 Patients With Breast Cancer.
    Clin Breast Cancer. 2019 Feb 20. pii: S1526-8209(18)30884.
    PubMed     Text format     Abstract available
    
    
    
41. GIULIANI J, Bonetti A
    Palbociclib or Ribociclib in First-Line Treatment in Patients With Hormone Receptor-Positive/Human Epidermal Receptor 2-Negative Advanced or Metastatic Breast Cancer? A Perspective Based on Pharmacologic Costs.
    Clin Breast Cancer. 2019 Feb 16. pii: S1526-8209(18)30803.
    PubMed     Text format     Abstract available
    
    
    
42. ARCIERO CA, Guo Y, Jiang R, Behera M, et al
    ER(+)/HER2(+) Breast Cancer Has Different Metastatic Patterns and Better Survival Than ER-/HER2(+) Breast Cancer.
    Clin Breast Cancer. 2019 Feb 14. pii: S1526-8209(18)30792.
    PubMed     Text format     Abstract available
    
    
    
43. XIE Y, Li Y, Zhang Y, Zhang S, et al
    Fulvestrant 500 mg Versus Exemestane in Postmenopausal Women With Metastatic Breast Cancer Resistant to Adjuvant Nonsteroidal Aromatase Inhibitors in Clinical Practice: A Multicenter Retrospective Study.
    Clin Breast Cancer. 2019 Feb 7. pii: S1526-8209(18)30801.
    PubMed     Text format     Abstract available
    
    
    
44. HENDERSON J, Adams P, Barber K
    Factors Determining Anthracycline Use in Hormone Receptor Positive, Early-Stage Breast Cancer.
    Clin Breast Cancer. 2019 Feb 7. pii: S1526-8209(18)30542.
    PubMed     Text format     Abstract available
    
    
    
45. KLAR N, Rosenzweig M, Diergaarde B, Brufsky A, et al
    Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30853.
    PubMed     Text format     Abstract available
    
    
    
46. O'BRIEN GL, O'Mahony C, Cooke K, Kinneally A, et al
    Cost Minimization Analysis of Intravenous or Subcutaneous Trastuzumab Treatment in Patients With HER2-Positive Breast Cancer in Ireland.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30526.
    PubMed     Text format     Abstract available
    
    
    
47. NATSIOPOULOS I, Intzes S, Liappis T, Zarampoukas K, et al
    Axillary Lymph Node Tattooing and Targeted Axillary Dissection in Breast Cancer Patients Who Presented as cN+ Before Neoadjuvant Chemotherapy and Became cN0 After Treatment.
    Clin Breast Cancer. 2019 Feb 6. pii: S1526-8209(18)30845.
    PubMed     Text format     Abstract available
    
    
    January 2019
48. FERRIGNI E, Bergom C, Yin Z, Szabo A, et al
    Breast Cancer in Women Aged 80 Years or Older: An Analysis of Treatment Patterns and Disease Outcomes.
    Clin Breast Cancer. 2019 Jan 31. pii: S1526-8209(18)30705.
    PubMed     Text format     Abstract available
    
    
    
49. HU J, Cuffolo G, Parulekar V, Chan V, et al
    The Results of Surveillance Imaging After Breast Conservation Surgery and Partial Breast Reconstruction With Chest Wall Perforator Flaps; A Qualitative Analysis Compared With Standard Breast-Conserving Surgery for Breast Cancer.
    Clin Breast Cancer. 2019 Jan 31. pii: S1526-8209(18)30842.
    PubMed     Text format     Abstract available
    
    
    
50. OGIYA R, Sagara Y, Niikura N, Freedman RA, et al
    Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer.
    Clin Breast Cancer. 2019 Jan 29. pii: S1526-8209(18)30604.
    PubMed     Text format     Abstract available
    
    
    
51. MAAJANI K, Jalali A, Alipour S, Khodadost M, et al
    The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2019 Jan 29. pii: S1526-8209(18)30780.
    PubMed     Text format     Abstract available
    
    
    
52. ALTUNDAG DK
    Prognostic Significance of Obesity and Diabetes Mellitus in Women With Brain Metastases From Breast Cancer Should Be Revisited.
    Clin Breast Cancer. 2019 Jan 23. pii: S1526-8209(19)30021.
    PubMed     Text format    
    
    
    
53. MEYER C, Millan P, Gonzalez V, Spera G, et al
    Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy.
    Clin Breast Cancer. 2019 Jan 23. pii: S1526-8209(18)30713.
    PubMed     Text format     Abstract available
    
    
    
54. TANGALAKIS LL, Cortina CS, Son JD, Poirier J, et al
    Obesity Does Not Influence Management of Advanced Breast Cancer in the Elderly.
    Clin Breast Cancer. 2019 Jan 12. pii: S1526-8209(18)30520.
    PubMed     Text format     Abstract available
    
    
    
55. CACHO-DIAZ B, Spinola-Marono H, Reynoso N, Gonzalez-Aguilar A, et al
    Role of Overweight, Obesity, and Comorbidities in the Prognosis of Patients With Breast Cancer With Brain Metastases.
    Clin Breast Cancer. 2019 Jan 7. pii: S1526-8209(18)30766.
    PubMed     Text format     Abstract available
    
    
    
56. MOTAWI TMK, Zakhary NI, Darwish HA, Abdalla HM, et al
    Significance of Serum Survivin and -31G/C Gene Polymorphism in the Early Diagnosis of Breast Cancer in Egypt.
    Clin Breast Cancer. 2019 Jan 6. pii: S1526-8209(18)30704.
    PubMed     Text format     Abstract available
    
    
    
57. HEMIDA MA, AbdElmoneim NA, Hewala TI, Rashad MM, et al
    Vitamin D Receptor in Breast Cancer Tissues and Its Relation to Estrogen Receptor Alpha (ER-alpha) Gene Expression and Serum 25-hydroxyvitamin D Levels in Egyptian Breast Cancer Patients: A Case-control Study.
    Clin Breast Cancer. 2019 Jan 6. pii: S1526-8209(18)30224.
    PubMed     Text format     Abstract available
    
    
    
58. PAPLOMATA E, Zelnak A, Santa-Maria CA, Liu Y, et al
    Use of Everolimus and Trastuzumab in Addition to Endocrine Therapy in Hormone-Refractory Metastatic Breast Cancer.
    Clin Breast Cancer. 2019 Jan 3. pii: S1526-8209(18)30637.
    PubMed     Text format     Abstract available
    
    
    December 2018
59. BLASCHKE SM, Gough KC, Chua BH, Francis PA, et al
    Implementation of a Multidisciplinary Model of Care for Women With Metastatic Breast Cancer: Challenges and Lessons Learned.
    Clin Breast Cancer. 2018 Dec 21. pii: S1526-8209(18)30567.
    PubMed     Text format     Abstract available
    
    
    
60. NOUR ELDIN EEM, El-Readi MZ, Nour Eldein MM, Alfalki AA, et al
    8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.
    Clin Breast Cancer. 2018 Dec 21. pii: S1526-8209(18)30631.
    PubMed     Text format     Abstract available
    
    
    
61. BLACKWELL KL, Zaman K, Qin S, Tkaczuk KHR, et al
    Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(18)30576.
    PubMed     Text format     Abstract available
    
    
    
62. TANINI S, Fisher AD, Meattini I, Bianchi S, et al
    Testosterone and Breast Cancer in Transmen: Case Reports, Review of the Literature, and Clinical Observation.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(18)30518.
    PubMed     Text format    
    
    
    
63. ORTEGA V, Anton A, Garau I, Afonso N, et al
    Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study.
    Clin Breast Cancer. 2018 Dec 20. pii: S1526-8209(17)30144.
    PubMed     Text format     Abstract available
    
    
    
64. LAN B, Ma F, Han M, Chen S, et al
    The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China.
    Clin Breast Cancer. 2018 Dec 19. pii: S1526-8209(18)30539.
    PubMed     Text format     Abstract available
    
    
    
65. KAPILA AK, Herd A, Knife N, Chaplin P, et al
    A Prospective Cohort Study on the Impact of Reflexology in Patients With Breast Cancer Using the MYCaW Scale.
    Clin Breast Cancer. 2018 Dec 19. pii: S1526-8209(18)30423.
    PubMed     Text format     Abstract available
    
    
    
66. SYMONDS L, Linden H, Gadi V, Korde L, et al
    Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer-A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib.
    Clin Breast Cancer. 2018 Dec 14. pii: S1526-8209(18)30655.
    PubMed     Text format     Abstract available
    
    
    
67. ABDEL-RAHMAN O, Xu Y, Kong S, Dort J, et al
    Impact of Baseline Cardiovascular Comorbidity on Outcomes in Women With Breast Cancer: A Real-world, Population-based Study.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30506.
    PubMed     Text format     Abstract available
    
    
    
68. VERNIERI C, Prisciandaro M, Milano M, Cona MS, et al
    Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30638.
    PubMed     Text format     Abstract available
    
    
    
69. DENG K, Mo S, Liu X, Chen J, et al
    Soy Foods Might Weaken the Sensitivity of Tamoxifen in Premenopausal Patients With Lumina A Subtype of Breast Cancer.
    Clin Breast Cancer. 2018 Dec 12. pii: S1526-8209(18)30645.
    PubMed     Text format     Abstract available
    
    
    
70. BONNER SN, Clark C, Keating NL, Kouri EM, et al
    Examining Associations of Racial Residential Segregation With Patient Knowledge of Breast Cancer and Treatment Receipt.
    Clin Breast Cancer. 2018 Dec 8. pii: S1526-8209(18)30417.
    PubMed     Text format     Abstract available
    
    
    November 2018
71. JACENE HA, Youn T, DiPiro PJ, Hu J, et al
    Metabolic Characterization of Inflammatory Breast Cancer With Baseline FDG-PET/CT: Relationship With Pathologic Response After Neoadjuvant Chemotherapy, Receptor Status, and Tumor Grade.
    Clin Breast Cancer. 2018 Nov 26. pii: S1526-8209(18)30508.
    PubMed     Text format     Abstract available
    
    
    
72. GAGNO S, D'Andrea MR, Mansutti M, Zanusso C, et al
    A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
    Clin Breast Cancer. 2018 Nov 24. pii: S1526-8209(18)30679.
    PubMed     Text format     Abstract available
    
    
    
73. THORNELOE RJ, Horne R, Side L, Wolf MS, et al
    Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study.
    Clin Breast Cancer. 2018 Nov 22. pii: S1526-8209(18)30533.
    PubMed     Text format     Abstract available
    
    
    
74. EISMANN J, Heng YJ, Fleischmann-Rose K, Tobias AM, et al
    Interdisciplinary Management of Transgender Individuals at Risk for Breast Cancer: Case Reports and Review of the Literature.
    Clin Breast Cancer. 2018 Nov 14. pii: S1526-8209(18)30569.
    PubMed     Text format    
    
    
    
75. TANG Y, Wang Y, Wang X, Liu Y, et al
    A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
    Clin Breast Cancer. 2018 Nov 14. pii: S1526-8209(18)30454.
    PubMed     Text format     Abstract available
    
    
    
76. MAINWARING W, Bowers J, Pham N, Pezzi T, et al
    Stereotactic Radiosurgery Versus Whole Brain Radiation Therapy: A Propensity Score Analysis and Predictors of Care for Patients With Brain Metastases From Breast Cancer.
    Clin Breast Cancer. 2018 Nov 12. pii: S1526-8209(18)30540.
    PubMed     Text format     Abstract available
    
    
    
77. CHEN H, Zhang M, Wang M, Zhang P, et al
    Immediate Breast Reconstruction in De Novo Metastatic Breast Cancer: An Analysis of 563 Cases Based on the SEER Database.
    Clin Breast Cancer. 2018 Nov 5. pii: S1526-8209(18)30678.
    PubMed     Text format     Abstract available
    
    
    
78. KOTOULA V, Tsakiri K, Koliou GA, Lazaridis G, et al
    Relapsed and De Novo Metastatic HER2-positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome.
    Clin Breast Cancer. 2018 Nov 5. pii: S1526-8209(18)30424.
    PubMed     Text format     Abstract available
    
    
    
79. XIPING Z, Shuai Z, Feijiang Y, Bo C, et al
    Meta-analysis of the Correlation Between Schizophrenia and Breast Cancer.
    Clin Breast Cancer. 2018 Nov 3. pii: S1526-8209(18)30090.
    PubMed     Text format     Abstract available
    
    
    
80. FARAROUEI M, Iqbal A, Rezaian S, Gheibi Z, et al
    Dietary Habits and Physical Activity are Associated With the Risk of Breast Cancer Among Young Iranian Women: A Case-control Study on 1010 Premenopausal Women.
    Clin Breast Cancer. 2018 Nov 2. pii: S1526-8209(18)30622.
    PubMed     Text format     Abstract available
    
    
    
81. CHEN W, Zhang J, Huang L, Chen L, et al
    Detection of HER2-positive Circulating Tumor Cells Using the LiquidBiopsy System in Breast Cancer.
    Clin Breast Cancer. 2018 Nov 1. pii: S1526-8209(18)30500.
    PubMed     Text format     Abstract available
    
    
    
82. WANG K, Zhu GQ, Shi Y, Li ZY, et al
    Long-Term Survival Differences Between T1-2 Invasive Lobular Breast Cancer and Corresponding Ductal Carcinoma After Breast-Conserving Surgery: A Propensity-Scored Matched Longitudinal Cohort Study.
    Clin Breast Cancer. 2018 Nov 1. pii: S1526-8209(18)30467.
    PubMed     Text format     Abstract available
    
    
    October 2018
83. BREAUX A, Turner B, Wu X, Rai SN, et al
    Impact of 21-Gene Expression Assay on Staging Estrogen Receptor-Positive HER2-Negative Breast Cancer.
    Clin Breast Cancer. 2018 Oct 29. pii: S1526-8209(18)30561.
    PubMed     Text format     Abstract available
    
    
    
84. BRANDINI DA SILVA FC, Jose da Silva J, Sarri AJ, Paiva CE, et al
    Comprehensive Validation Study of Quality-of-Life Questionnaire Using Objective Clinical Measures: Breast Cancer Treatment Outcome Scale (BCTOS), Brazilian Portuguese Version.
    Clin Breast Cancer. 2018 Oct 27. pii: S1526-8209(18)30512.
    PubMed     Text format     Abstract available
    
    
    
85. PASSILDAS J, Collard O, Savoye AM, Dohou J, et al
    Impact of Chemotherapy-induced Menopause in Women of Childbearing Age With Non-metastatic Breast Cancer - Preliminary Results From the MENOCOR Study.
    Clin Breast Cancer. 2018 Oct 23. pii: S1526-8209(18)30373.
    PubMed     Text format     Abstract available
    
    
    
86. HURRIA A, Soto-Perez-de-Celis E, Blanchard S, Burhenn P, et al
    A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and Oncology.
    Clin Breast Cancer. 2018 Oct 16. pii: S1526-8209(18)30328.
    PubMed     Text format     Abstract available
    
    
    
87. DING S, Wu J, Lin C, Chen W, et al
    Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.
    Clin Breast Cancer. 2018 Oct 13. pii: S1526-8209(18)30393.
    PubMed     Text format     Abstract available
    
    
    
88. KAUFMAN PA, Wildiers H, Freyer G, Kemeny M, et al
    Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Oct 9. pii: S1526-8209(18)30451.
    PubMed     Text format     Abstract available
    
    
    
89. PANDEY A, Brufsky AM
    Metastatic Breast Cancer Patient With Activating HER2 Exon 20 Insertion Mutation With Response to Poziotinib: Case Report of Compassionate Drug Use.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30317.
    PubMed     Text format    
    
    
    
90. XIAO YL, Wang K, Liu Q, Li J, et al
    Risk Reduction and Survival Benefit of Risk-Reducing Salpingo-oophorectomy in Hereditary Breast Cancer: Meta-analysis and Systematic Review.
    Clin Breast Cancer. 2018 Oct 4. pii: S1526-8209(18)30521.
    PubMed     Text format     Abstract available
    
    
    
91. KAPILA AK, Hamdi M, Patel A
    Clinicians Should Actively Promote Exercise in Survivors of Breast Cancer.
    Clin Breast Cancer. 2018;18:e747-e749.
    PubMed     Text format     Abstract available
    
    
    
92. GINZAC A, Thivat E, Mouret-Reynier MA, Dubray-Longeras P, et al
    Weight Evolution During Endocrine Therapy for Breast Cancer in Postmenopausal Patients: Effect of Initial Fat Mass Percentage and Previous Adjuvant Treatments.
    Clin Breast Cancer. 2018;18:e1093-e1102.
    PubMed     Text format     Abstract available
    
    
    September 2018
93. PAN H, Zhang K, Wang M, Ling L, et al
    Palliative Local Surgery for Locally Advanced Breast Cancer Depending on Hormone Receptor Status in Elderly Patients.
    Clin Breast Cancer. 2018 Sep 27. pii: S1526-8209(18)30510.
    PubMed     Text format     Abstract available
    
    
    
94. NAKAGAWA M, Ikeuchi M, Morimoto M, Takechi H, et al
    Phase II Study of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy for Operable Breast Cancer Patients (N-1 Study).
    Clin Breast Cancer. 2018 Sep 27. pii: S1526-8209(18)30262.
    PubMed     Text format     Abstract available
    
    
    
95. KOWALCZYK R, Nowosielski K, Cedrych I, Krzystanek M, et al
    Factors Affecting Sexual Function and Body Image of Early-Stage Breast Cancer Survivors in Poland: A Short-Term Observation.
    Clin Breast Cancer. 2018 Sep 21. pii: S1526-8209(18)30474.
    PubMed     Text format     Abstract available
    
    
    
96. BAWAZIR A, Bashateh N, Jradi H, Breik AB, et al
    Breast Cancer Screening Awareness and Practices Among Women Attending Primary Health Care Centers in the Ghail Bawazir District of Yemen.
    Clin Breast Cancer. 2018 Sep 20. pii: S1526-8209(18)30429.
    PubMed     Text format     Abstract available
    
    
    
97. SHAKER OG, Senousy MA
    Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
    Clin Breast Cancer. 2018 Sep 19. pii: S1526-8209(18)30444.
    PubMed     Text format     Abstract available
    
    
    
98. WATSON GA, Deac O, Aslam R, O'Dwyer R, et al
    Real-World Experience of Palbociclib-Induced Adverse Events and Compliance With Complete Blood Count Monitoring in Women With Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer.
    Clin Breast Cancer. 2018 Sep 8. pii: S1526-8209(18)30507.
    PubMed     Text format     Abstract available
    
    
    
99. HSU W, Zhou X, Petruse A, Chau N, et al
    Role of Clinical and Imaging Risk Factors in Predicting Breast Cancer Diagnosis Among BI-RADS 4 Cases.
    Clin Breast Cancer. 2018 Sep 5. pii: S1526-8209(18)30258.
    PubMed     Text format     Abstract available
    
    
    
100. MCGEE SF, Vandermeer L, Mazzarello S, Sienkiewicz M, et al
     Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients.
     Clin Breast Cancer. 2018 Sep 4. pii: S1526-8209(18)30204.
     PubMed     Text format     Abstract available
     
     
     August 2018
101. BERHILI S, Ouabdelmoumen A, Sbai A, Kebdani T, et al
     Radical Mastectomy Increases Psychological Distress in Young Breast Cancer Patients: Results of A Cross-sectional Study.
     Clin Breast Cancer. 2018 Aug 31. pii: S1526-8209(18)30522.
     PubMed     Text format     Abstract available
     
     
     
102. XIE J, Yang Y, Sun J, Jiao Z, et al
     STEAP1 Inhibits Breast Cancer Metastasis and Is Associated With Epithelial-Mesenchymal Transition Procession.
     Clin Breast Cancer. 2018 Aug 30. pii: S1526-8209(18)30378.
     PubMed     Text format     Abstract available
     
     
     
103. HAYASHI N, Tsunoda H, Namura M, Ochi T, et al
     Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients.
     Clin Breast Cancer. 2018 Aug 24. pii: S1526-8209(18)30234.
     PubMed     Text format     Abstract available
     
     
     
104. YARDLEY DA, Shipley D, Zubkus J, Wright GL, et al
     A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer.
     Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30132.
     PubMed     Text format     Abstract available
     
     
     
105. PISTILLI B, Mazouni C, Zingarello A, Faron M, et al
     Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.
     Clin Breast Cancer. 2018 Aug 23. pii: S1526-8209(18)30264.
     PubMed     Text format     Abstract available
     
     
     
106. HAMMER J, Geinitz H, Nieder C, Track C, et al
     Risk Factors for Local Relapse and Inferior Disease-free Survival After Breast-conserving Management of Breast Cancer: Recursive Partitioning Analysis of 2161 Patients.
     Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30241.
     PubMed     Text format     Abstract available
     
     
     
107. ALARCON ROJAS CA, Alvarez-Banuelos MT, Morales-Romero J, Suarez-Diaz H, et al
     Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico.
     Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30366.
     PubMed     Text format     Abstract available
     
     
     
108. THRIVENI K, Raju A, Kumar RV, Krishnamurthy S, et al
     Patterns of Relative Telomere Length is Associated With hTERT Gene Expression in the Tissue of Patients With Breast Cancer.
     Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30372.
     PubMed     Text format     Abstract available
     
     
     
109. YAN M, Abdi MA, Falkson C
     Axillary Management in Breast Cancer Patients: A Comprehensive Review of the Key Trials.
     Clin Breast Cancer. 2018 Aug 22. pii: S1526-8209(18)30448.
     PubMed     Text format     Abstract available
     
     
     
110. GUILLEMOIS S, Patsouris A, Peyraga G, Chassain K, et al
     Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report.
     Clin Breast Cancer. 2018 Aug 14. pii: S1526-8209(18)30313.
     PubMed     Text format    
     
     
     
111. MARSCHNER N, Salat C, Soling U, Hansen R, et al
     Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel.
     Clin Breast Cancer. 2018 Aug 9. pii: S1526-8209(18)30064.
     PubMed     Text format     Abstract available
     
     
     
112. RUGO HS, Roche H, Thomas E, Chung HC, et al
     Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials.
     Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30266.
     PubMed     Text format     Abstract available
     
     
     
113. SPORIKOVA Z, Koudelakova V, Trojanec R, Hajduch M, et al
     Genetic Markers in Triple-Negative Breast Cancer.
     Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30093.
     PubMed     Text format     Abstract available
     
     
     
114. HE J, Gu Y, Zhang S
     Vitamin A and Breast Cancer Survival: A Systematic Review and Meta-analysis.
     Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30305.
     PubMed     Text format     Abstract available
     
     
     
115. JI G, Zhang C, Guan S, Yao X, et al
     Erlotinib for Progressive Brain and Leptomeningeal Metastases From HER2-positive Breast Cancer After Treatment Failure With Trastuzumab and Lapatinib: Experience and Review of Literature.
     Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30384.
     PubMed     Text format    
     
     
     July 2018
116. STEARNS V, Brufsky AM, Verma S, Cotter MJ, et al
     Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
     Clin Breast Cancer. 2018 Jul 30. pii: S1526-8209(18)30306.
     PubMed     Text format     Abstract available
     
     
     
117. RAPHAEL J, Kiss A, Nofech-Mozes S, Trudeau M, et al
     Clinical Outcomes of Single Versus Double Hormone Receptor-Positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
     Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30118.
     PubMed     Text format     Abstract available
     
     
     
118. ALI OS, Shabayek MI, Seleem MM, Abdellateif HG, et al
     MicroRNAs 182 and 375 Sera Expression as Prognostic Biochemical Markers in Breast Cancer.
     Clin Breast Cancer. 2018 Jul 29. pii: S1526-8209(18)30232.
     PubMed     Text format     Abstract available
     
     
     
119. ABDEL-RAHMAN O
     Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials.
     Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30085.
     PubMed     Text format     Abstract available
     
     
     
120. CHEN X, Fan Y, Xu B
     Distinct Characteristics and Metastatic Behaviors of Late Recurrence in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: A Single Institute Experience of More Than 10 Years.
     Clin Breast Cancer. 2018 Jul 24. pii: S1526-8209(18)30303.
     PubMed     Text format     Abstract available
     
     
     
121. KURUNDKAR A, Gao X, Zhang K, Britt JP, et al
     Comparison of AJCC Anatomic and Clinical Prognostic Stage Groups in Breast Cancer: Analysis of 3322 Cases From a Single Institution.
     Clin Breast Cancer. 2018 Jul 17. pii: S1526-8209(18)30230.
     PubMed     Text format     Abstract available
     
     
     
122. BUECHLER SA, Gokmen-Polar Y, Badve SS
     EarlyR: A Robust Gene Expression Signature for Predicting Outcomes of Estrogen Receptor-Positive Breast Cancer.
     Clin Breast Cancer. 2018 Jul 17. pii: S1526-8209(18)30012.
     PubMed     Text format     Abstract available
     
     
     
123. MURTHY RK, Raghavendra AS, Hess KR, Fujii T, et al
     Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience.
     Clin Breast Cancer. 2018 Jul 10. pii: S1526-8209(18)30009.
     PubMed     Text format     Abstract available
     
     
     
124. LELIEVRE L, Clezardin P, Magaud L, Roche L, et al
     Comparative Study of Neoadjuvant Chemotherapy With and Without Zometa for Management of Locally Advanced Breast Cancer With Serum VEGF as Primary Endpoint: The NEOZOL Study.
     Clin Breast Cancer. 2018 Jul 10. pii: S1526-8209(18)30121.
     PubMed     Text format     Abstract available
     
     
     
125. ABD-ELHAY FA, Elhusseiny KM, Kamel MG, Low SK, et al
     Negative Lymph Node Count and Lymph Node Ratio Are Associated With Survival in Male Breast Cancer.
     Clin Breast Cancer. 2018 Jul 7. pii: S1526-8209(18)30061.
     PubMed     Text format     Abstract available
     
     
     
126. BAXTER DE, Kim B, Hanby AM, Verghese ET, et al
     Neoadjuvant Endocrine Therapy in Breast Cancer Upregulates the Cytotoxic Drug Pump ABCG2/BCRP, and May Lead to Resistance to Subsequent Chemotherapy.
     Clin Breast Cancer. 2018 Jul 6. pii: S1526-8209(18)30447.
     PubMed     Text format     Abstract available
     
     
     
127. YEE C, Wang K, Asthana R, Drost L, et al
     Radiation-induced Skin Toxicity in Breast Cancer Patients: A Systematic Review of Randomized Trials.
     Clin Breast Cancer. 2018 Jul 4. pii: S1526-8209(18)30114.
     PubMed     Text format     Abstract available
     
     
     June 2018
128. LIU N, Johnson KJ, Ma CX
     Male Breast Cancer: An Updated Surveillance, Epidemiology, and End Results Data Analysis.
     Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(18)30016.
     PubMed     Text format     Abstract available
     
     
     
129. WANG J, Wang S, Tang Y, Jing H, et al
     Comparison of Treatment Outcomes With Breast-conserving Surgery Plus Radiotherapy Versus Mastectomy for Patients With Stage I Breast Cancer: A Propensity Score-matched Analysis.
     Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(18)30115.
     PubMed     Text format     Abstract available
     
     
     
130. KUWAYAMA T, Nakamura S, Hayashi N, Takano T, et al
     Randomized Multicenter Phase II Trial of Neoadjuvant Therapy Comparing Weekly Nab-paclitaxel Followed by FEC With Docetaxel Followed by FEC in HER2(-) Early-stage Breast Cancer.
     Clin Breast Cancer. 2018 Jun 27. pii: S1526-8209(16)30572.
     PubMed     Text format     Abstract available
     
     
     
131. NASEHI L, Sturgis CD, Sharma N, Turk P, et al
     Breast Cancer Risk Associated With Benign Intraductal Papillomas Initially Diagnosed on Core Needle Biopsy.
     Clin Breast Cancer. 2018 Jun 21. pii: S1526-8209(18)30228.
     PubMed     Text format     Abstract available
     
     
     
132. SHEEHY EM, Lehane E, Quinn E, Livingstone V, et al
     Information Needs of Patients With Breast Cancer at Years One, Three, and Five After Diagnosis.
     Clin Breast Cancer. 2018 Jun 18. pii: S1526-8209(18)30130.
     PubMed     Text format     Abstract available
     
     
     
133. CHEN J, Wu X, Christos P, Yan W, et al
     Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis.
     Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(17)30641.
     PubMed     Text format     Abstract available
     
     
     
134. ZHU X, Huang JM, Zhang K, Xia LJ, et al
     Diagnostic Value of Contrast-Enhanced Spectral Mammography for Screening Breast Cancer: Systematic Review and Meta-analysis.
     Clin Breast Cancer. 2018 Jun 15. pii: S1526-8209(18)30008.
     PubMed     Text format     Abstract available
     
     
     
135. KIM Y, Sim SH, Park B, Lee KS, et al
     Magnetic Resonance Imaging (MRI) Assessment of Residual Breast Cancer After Neoadjuvant Chemotherapy: Relevance to Tumor Subtypes and MRI Interpretation Threshold.
     Clin Breast Cancer. 2018 Jun 7. pii: S1526-8209(18)30300.
     PubMed     Text format     Abstract available
     
     
     
136. MORI H, Kubo M, Kai M, Velasquez VV, et al
     BRCAness Combined With a Family History of Cancer Is Associated With a Poor Prognosis for Breast Cancer Patients With a High Risk of BRCA Mutations.
     Clin Breast Cancer. 2018 Jun 2. pii: S1526-8209(18)30022.
     PubMed     Text format     Abstract available
     
     
     May 2018
137. SIOTOS C, McColl M, Psoter K, Gilmore RC, et al
     Tumor Site and Breast Cancer Prognosis.
     Clin Breast Cancer. 2018 May 29. pii: S1526-8209(18)30299.
     PubMed     Text format     Abstract available
     
     
     
138. KIM HJ, Kang E, Kim JH, Kim SH, et al
     Survival Benefit of Surgical Removal of Primary Tumor in Patients With Stage IV Breast Cancer.
     Clin Breast Cancer. 2018 May 28. pii: S1526-8209(18)30104.
     PubMed     Text format     Abstract available
     
     
     
139. CHEN M, Pockaj B, Andreozzi M, Barrett MT, et al
     JAK2 and PD-L1 Amplification Enhance the Dynamic Expression of PD-L1 in Triple-negative Breast Cancer.
     Clin Breast Cancer. 2018 May 26. pii: S1526-8209(17)30780.
     PubMed     Text format     Abstract available
     
     
     
140. LECLERC AF, Slomian J, Jerusalem G, Coucke P, et al
     Exercise and Education Program After Breast Cancer: Benefits on Quality of Life and Symptoms at 3, 6, 12, and 24 Months' Follow-up.
     Clin Breast Cancer. 2018 May 19. pii: S1526-8209(17)30809.
     PubMed     Text format     Abstract available
     
     
     
141. CO M, Ng J, Kwong A
     Air Travel Safety in Postoperative Breast Cancer Patients: A Systematic Review.
     Clin Breast Cancer. 2018 May 17. pii: S1526-8209(18)30236.
     PubMed     Text format     Abstract available
     
     
     
142. KOZAK MM, Jacobson CE, von Eyben R, Walck E, et al
     Patterns of Distant Failure by Intrinsic Breast Cancer Subtype in Premenopausal Women Treated With Neoadjuvant Chemotherapy.
     Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30796.
     PubMed     Text format     Abstract available
     
     
     
143. MCINTIRE PJ, Irshaid L, Liu Y, Chen Z, et al
     Hot Spot and Whole-Tumor Enumeration of CD8(+) Tumor-Infiltrating Lymphocytes Utilizing Digital Image Analysis Is Prognostic in Triple-Negative Breast Cancer.
     Clin Breast Cancer. 2018 May 7. pii: S1526-8209(17)30839.
     PubMed     Text format     Abstract available
     
     
     
144. DENG Y, Ma G, Li W, Wang T, et al
     CDK4/6 Inhibitors in Combination With Hormone Therapy for HR(+)/HER2(-) Advanced Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
     Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30798.
     PubMed     Text format     Abstract available
     
     
     
145. JABIR RS, Ho GF, Annuar MABA, Stanslas J, et al
     Association of Allelic Interaction of Single Nucleotide Polymorphisms of Influx and Efflux Transporters Genes With Nonhematologic Adverse Events of Docetaxel in Breast Cancer Patients.
     Clin Breast Cancer. 2018 May 4. pii: S1526-8209(17)30628.
     PubMed     Text format     Abstract available
     
     
     April 2018
146. LADWA R, Kalas T, Pathmanathan S, Woodward N, et al
     Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer.
     Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30105.
     PubMed     Text format     Abstract available
     
     
     
147. DHAKAL A, Matthews CM, Levine EG, Salerno KE, et al
     Efficacy of Palbociclib Combinations in Hormone Receptor-Positive Metastatic Breast Cancer Patients After Prior Everolimus Treatment.
     Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30805.
     PubMed     Text format     Abstract available
     
     
     
148. KOPS NL, Bessel M, Caleffi M, Ribeiro RA, et al
     Body Weight and Breast Cancer: Nested Case-Control Study in Southern Brazil.
     Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(18)30073.
     PubMed     Text format     Abstract available
     
     
     
149. RAYSON D, Payne JI, Michael JCR, Tsuruda KM, et al
     Impact of Detection Method and Age on Survival Outcomes in Triple-Negative Breast Cancer: A Population-Based Cohort Analysis.
     Clin Breast Cancer. 2018 Apr 28. pii: S1526-8209(17)30829.
     PubMed     Text format     Abstract available
     
     
     
150. CHO WK, Choi DH, Park W, Cha H, et al
     Effect of Body Mass Index on Survival in Breast Cancer Patients According to Subtype, Metabolic Syndrome, and Treatment.
     Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(17)30765.
     PubMed     Text format     Abstract available
     
     
     
151. QINGQING H, Jian Z, Dayong Z, Ziyi F, et al
     Robot-Assisted Internal Mammary Lymph Node Chain Dissection for Breast Cancer.
     Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30134.
     PubMed     Text format    
     
     
     
152. KIM HJ, Lee MH, Lee JE, Park S, et al
     Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy.
     Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30019.
     PubMed     Text format     Abstract available
     
     
     
153. HU ZY, Xiao H, Xiao M, Tang Y, et al
     Inducing or Preventing Subsequent Malignancies for Breast Cancer Survivors? Double-edged Sword of Estrogen Receptor and Progesterone Receptor.
     Clin Breast Cancer. 2018 Apr 19. pii: S1526-8209(18)30048.
     PubMed     Text format     Abstract available
     
     
     
154. KENDZIERSKI DC, Schneider BP, Kiel PJ
     Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review.
     Clin Breast Cancer. 2018 Apr 18. pii: S1526-8209(17)30722.
     PubMed     Text format     Abstract available
     
     
     
155. CADOO KA, Kaufman PA, Seidman AD, Chang C, et al
     Phase 2 Study of Dose-Dense Doxorubicin and Cyclophosphamide Followed by Eribulin Mesylate With or Without Prophylactic Growth Factor for Adjuvant Treatment of Early-Stage Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer.
     Clin Breast Cancer. 2018 Apr 7. pii: S1526-8209(17)30768.
     PubMed     Text format     Abstract available
     
     
     
156. NG T, Phey XY, Yeo HL, Shwe M, et al
     Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
     Clin Breast Cancer. 2018 Apr 6. pii: S1526-8209(17)30767.
     PubMed     Text format     Abstract available
     
     
     
157. MUTSCHLER NS, Scholz C, Friedl TWP, Zwingers T, et al
     Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
     Clin Breast Cancer. 2018;18:175-183.
     PubMed     Text format     Abstract available
     
     
     March 2018
158. CORTES J, Perez-Garcia J, Whiting S, Wan Y, et al
     Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.
     Clin Breast Cancer. 2018 Mar 30. pii: S1526-8209(17)30778.
     PubMed     Text format     Abstract available
     
     
     
159. KIM S, Moon BI, Lim W, Park S, et al
     Feasibility of Classification of Triple Negative Breast Cancer by Immunohistochemical Surrogate Markers.
     Clin Breast Cancer. 2018 Mar 23. pii: S1526-8209(17)30736.
     PubMed     Text format     Abstract available
     
     
     
160. TAHERIPANAH R, Balash F, Anbiaee R, Mahmoodi M, et al
     Breast Cancer and Ovulation Induction Treatments.
     Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30455.
     PubMed     Text format     Abstract available
     
     
     
161. MORRIS PG, Rota S, Cadoo K, Zamora S, et al
     Phase II Study of Paclitaxel and Dasatinib in Metastatic Breast Cancer.
     Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30810.
     PubMed     Text format     Abstract available
     
     
     
162. UM E, Kang JW, Lee S, Kim HJ, et al
     Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
     Clin Breast Cancer. 2018 Mar 15. pii: S1526-8209(17)30614.
     PubMed     Text format     Abstract available
     
     
     
163. MATTHIESSEN LW, Keshtgar M, Curatolo P, Kunte C, et al
     Electrochemotherapy for Breast Cancer-Results From the INSPECT Database.
     Clin Breast Cancer. 2018 Mar 14. pii: S1526-8209(17)30397.
     PubMed     Text format     Abstract available
     
     
     
164. REINERT T, Nogueira-Rodrigues A, Kestelman FP, Ashton-Prolla P, et al
     The Challenge of Evaluating Adnexal Masses in Patients With Breast Cancer.
     Clin Breast Cancer. 2018 Mar 12. pii: S1526-8209(18)30026.
     PubMed     Text format     Abstract available
     
     
     
165. MIYAGAWA Y, Araki K, Bun A, Ozawa H, et al
     Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
     Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30724.
     PubMed     Text format     Abstract available
     
     
     
166. COSPHIADI I, Atmakusumah TD, Siregar NC, Muthalib A, et al
     Bone Metastasis in Advanced Breast Cancer: Analysis of Gene Expression Microarray.
     Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30777.
     PubMed     Text format     Abstract available
     
     
     
167. YARDLEY DA, Hart LL, Ward PJ, Wright GL, et al
     Cabazitaxel Plus Lapatinib as Therapy for HER2(+) Metastatic Breast Cancer With Intracranial Metastases: Results of a Dose-finding Study.
     Clin Breast Cancer. 2018 Mar 8. pii: S1526-8209(17)30668.
     PubMed     Text format     Abstract available
     
     
     
168. MEATTINI I, Pezzulla D, Saieva C, Bernini M, et al
     Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study.
     Clin Breast Cancer. 2018 Mar 2. pii: S1526-8209(18)30015.
     PubMed     Text format     Abstract available
     
     
     February 2018
169. BINKLEY JM, Stratford P, Kirkpatrick S, Farley CR, et al
     Estimating the Reliability and Validity of the Upper Extremity Functional Index in Women After Breast Cancer Surgery.
     Clin Breast Cancer. 2018 Feb 21. pii: S1526-8209(18)30054.
     PubMed     Text format     Abstract available
     
     
     
170. DEFAZIO MV, Dervishaj OA, Bozzuto LM, Pittman TA, et al
     Delayed Recurrent and Bilateral Breast Cancer in Patients With Partial Poland's Anomaly: Report of 2 Rare Cases and Review of the Literature.
     Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30842.
     PubMed     Text format    
     
     
     
171. HERSKOVIC AC, Wu X, Christos PJ, Nagar H, et al
     Omission of Adjuvant Radiotherapy in the Elderly Breast Cancer Patient: Missed Opportunity?
     Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(17)30782.
     PubMed     Text format     Abstract available
     
     
     
172. RAO N, Chen K, Yang Q, Niu J, et al
     Proof-of-Concept Study of 3-D-Printed Mold-Guided Breast-Conserving Surgery in Breast Cancer Patients.
     Clin Breast Cancer. 2018 Feb 20. pii: S1526-8209(18)30039.
     PubMed     Text format     Abstract available
     
     
     
173. YAMASHITA N, Tokunaga E, Iimori M, Inoue Y, et al
     Epithelial Paradox: Clinical Significance of Coexpression of E-cadherin and Vimentin With Regard to Invasion and Metastasis of Breast Cancer.
     Clin Breast Cancer. 2018 Feb 16. pii: S1526-8209(17)30629.
     PubMed     Text format     Abstract available
     
     
     
174. ZAHEDI H, Djalalinia S, Sadeghi O, Asayesh H, et al
     Dietary Inflammatory Potential Score and Risk of Breast Cancer: Systematic Review and Meta-analysis.
     Clin Breast Cancer. 2018 Feb 7. pii: S1526-8209(17)30725.
     PubMed     Text format     Abstract available
     
     
     
175. PALAZZO A, Dellapasqua S, Munzone E, Bagnardi V, et al
     Phase II Trial of Bevacizumab Plus Weekly Paclitaxel, Carboplatin, and Metronomic Cyclophosphamide With or Without Trastuzumab and Endocrine Therapy as Preoperative Treatment of Inflammatory Breast Cancer.
     Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30737.
     PubMed     Text format     Abstract available
     
     
     
176. CUI Q, Kong D, Li Z, Ahiable P, et al
     Dachshund 1 is Differentially Expressed Between Male and Female Breast Cancer: A Matched Case-Control Study of Clinical Characteristics and Prognosis.
     Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30662.
     PubMed     Text format     Abstract available
     
     
     
177. BLACKWELL K, Gligorov J, Jacobs I, Twelves C, et al
     The Global Need for a Trastuzumab Biosimilar for Patients With HER2-Positive Breast Cancer.
     Clin Breast Cancer. 2018 Feb 2. pii: S1526-8209(17)30406.
     PubMed     Text format     Abstract available
     
     
     January 2018
178. HASHEMI M, Sanaei S, Hashemi SM, Eskandari E, et al
     Association of Single Nucleotide Polymorphisms of the MDM4 Gene With the Susceptibility to Breast Cancer in a Southeast Iranian Population Sample.
     Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30804.
     PubMed     Text format     Abstract available
     
     
     
179. ERSOY YE, Kadioglu H
     Review of Novel Sentinel Lymph Node Biopsy Techniques in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
     Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30830.
     PubMed     Text format     Abstract available
     
     
     
180. JABIR FA, Hoidy WH
     Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women.
     Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(17)30534.
     PubMed     Text format     Abstract available
     
     
     
181. FARD ZT, Nafisi N
     The Relationship Between 6 Polymorphisms of Caveolin-1 Gene and the Risk of Breast Cancer.
     Clin Breast Cancer. 2018 Jan 31. pii: S1526-8209(16)30439.
     PubMed     Text format     Abstract available
     
     
     
182. KOJIMA Y, Kawamoto H, Nishikawa T, Hayami R, et al
     Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m(2)) Followed by Fluorouracil, Epirubicin, and Cyclophosphamide Therapy as Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.
     Clin Breast Cancer. 2018 Jan 11. pii: S1526-8209(17)30615.
     PubMed     Text format     Abstract available
     
     
     
183. GU J, Groot G, Boden C, Busch A, et al
     Review of Factors Influencing Women's Choice of Mastectomy Versus Breast Conserving Therapy in Early Stage Breast Cancer: A Systematic Review.
     Clin Breast Cancer. 2018 Jan 3. pii: S1526-8209(17)30691.
     PubMed     Text format     Abstract available
     
     
     December 2017
184. YADAV S, Ladkany R, Yadav D, Alhalabi O, et al
     Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer.
     Clin Breast Cancer. 2017 Dec 30. pii: S1526-8209(17)30334.
     PubMed     Text format     Abstract available
     
     
     
185. WU JD, Hong CQ, Huang WH, Wei XL, et al
     L1 Cell Adhesion Molecule and Its Soluble Form sL1 Exhibit Poor Prognosis in Primary Breast Cancer Patients.
     Clin Breast Cancer. 2017 Dec 28. pii: S1526-8209(17)30523.
     PubMed     Text format     Abstract available
     
     
     
186. BHAVE MA, Speth KA, Kidwell KM, Lyden A, et al
     Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.
     Clin Breast Cancer. 2017 Dec 27. pii: S1526-8209(17)30624.
     PubMed     Text format     Abstract available
     
     
     
187. MORIKAWA A, Wang R, Patil S, Diab A, et al
     Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
     Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30394.
     PubMed     Text format     Abstract available
     
     
     
188. GORNSTEIN EL, Sandefur S, Chung JH, Gay LM, et al
     BRCA2 Reversion Mutation Associated With Acquired Resistance to Olaparib in Estrogen Receptor-positive Breast Cancer Detected by Genomic Profiling of Tissue and Liquid Biopsy.
     Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30680.
     PubMed     Text format    
     
     
     
189. YERUVA SLH, Javadi MS, Stearns V
     Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
     Clin Breast Cancer. 2017 Dec 21. pii: S1526-8209(17)30533.
     PubMed     Text format    
     
     
     
190. MEISEL J, Zhang C, Neely C, Mendoza P, et al
     Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score.
     Clin Breast Cancer. 2017 Dec 14. pii: S1526-8209(17)30562.
     PubMed     Text format     Abstract available
     
     
     
191. MOLDERINGS GJ, Knuchel-Clarke R, Hertfelder HJ, Kuhl C, et al
     Mast Cell Activation Syndrome Mimicking Breast Cancer: Case Report With Pathophysiologic Considerations.
     Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30532.
     PubMed     Text format    
     
     
     
192. KUBA S, Maeda S, Matsumoto M, Yamanouchi K, et al
     Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
     Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30626.
     PubMed     Text format     Abstract available
     
     
     
193. SHEPPARD VB, de Mendoza AH, He J, Jennings Y, et al
     Initiation of Adjuvant Endocrine Therapy in Black and White Women With Breast Cancer.
     Clin Breast Cancer. 2017 Dec 12. pii: S1526-8209(17)30356.
     PubMed     Text format     Abstract available
     
     
     
194. CHIBA A, Raman R, Thomas A, Lamy PJ, et al
     Serum Vitamin D Levels Affect Pathologic Complete Response in Patients Undergoing Neoadjuvant Systemic Therapy for Operable Breast Cancer.
     Clin Breast Cancer. 2017 Dec 11. pii: S1526-8209(17)30324.
     PubMed     Text format     Abstract available
     
     
     
195. ELGHOROURY EA, ElDine HG, Kamel SA, Abdelrahman AH, et al
     Evaluation of miRNA-21 and miRNA Let-7 as Prognostic Markers in Patients With Breast Cancer.
     Clin Breast Cancer. 2017 Dec 7. pii: S1526-8209(17)30458.
     PubMed     Text format     Abstract available
     
     
     
196. SCIMECA M, Antonacci C, Toschi N, Giannini E, et al
     Breast Osteoblast-like Cells: A Reliable Early Marker for Bone Metastases From Breast Cancer.
     Clin Breast Cancer. 2017 Dec 5. pii: S1526-8209(17)30209.
     PubMed     Text format     Abstract available
     
     
     November 2017
197. BASTIAANNET E, Charman J, Johannesen TB, Schrodi S, et al
     A European, Observational Study of Endocrine Therapy Administration in Patients With an Initial Diagnosis of Hormone Receptor-Positive Advanced Breast Cancer.
     Clin Breast Cancer. 2017 Nov 29. pii: S1526-8209(17)30728.
     PubMed     Text format     Abstract available
     
     
     
198. LANDMAN Y, Ilouze M, Wein S, Neiman V, et al
     Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.
     Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30561.
     PubMed     Text format    
     
     
     
199. HAMELINCK VC, Bastiaannet E, Pieterse AH, van de Velde CJH, et al
     Preferred and Perceived Participation of Younger and Older Patients in Decision Making About Treatment for Early Breast Cancer: A Prospective Study.
     Clin Breast Cancer. 2017 Nov 28. pii: S1526-8209(17)30409.
     PubMed     Text format     Abstract available
     
     
     
200. RASOOL I, Afroze D, Wani KA, Yousuf A, et al
     Role of the Functional Polymorphism of Survivin Gene (-31G/C) and Risk of Breast Cancer in a North Indian Population.
     Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30631.
     PubMed     Text format     Abstract available
     
     
     
201. FURRER D, Jacob S, Michaud A, Provencher L, et al
     Association of Tobacco Use, Alcohol Consumption and HER2 Polymorphisms With Response to Trastuzumab in HER2-Positive Breast Cancer Patients.
     Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30318.
     PubMed     Text format     Abstract available
     
     
     
202. FLEMING CA, McCarthy K, Ryan C, McCarthy A, et al
     Evaluation of Discordance in Primary Tumor and Lymph Node Response After Neoadjuvant Therapy in Breast Cancer.
     Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30679.
     PubMed     Text format     Abstract available
     
     
     
203. CHANG HT, Pan HJ, Lee CH
     Prevention of Tamoxifen-related Nonalcoholic Fatty Liver Disease in Breast Cancer Patients.
     Clin Breast Cancer. 2017 Nov 23. pii: S1526-8209(17)30357.
     PubMed     Text format     Abstract available
     
     
     
204. KIM JY, Jung EJ, Park HJ, Lee JH, et al
     Tumor-Suppressing Effect of Silencing of Annexin A3 Expression in Breast Cancer.
     Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30504.
     PubMed     Text format     Abstract available
     
     
     
205. INOUE Y, Yamashita N, Kitao H, Tanaka K, et al
     Clinical Significance of the Wild Type p53-Induced Phosphatase 1 Expression in Invasive Breast Cancer.
     Clin Breast Cancer. 2017 Nov 21. pii: S1526-8209(17)30385.
     PubMed     Text format     Abstract available
     
     
     
206. GRANDI G, Toss A, Cagnacci A, Marcheselli L, et al
     Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History.
     Clin Breast Cancer. 2017 Nov 14. pii: S1526-8209(17)30488.
     PubMed     Text format     Abstract available
     
     
     
207. CHKHEIDZE R, Sanders MAG, Haley B, Leitch AM, et al
     Isolated Contralateral Axillary Lymph Node Involvement in Breast Cancer Represents a Locally Advanced Disease Not Distant Metastases.
     Clin Breast Cancer. 2017 Nov 10. pii: S1526-8209(17)30456.
     PubMed     Text format     Abstract available
     
     
     
208. KARAKAS Y, Dizdar O, Aksoy S, Hayran M, et al
     The Effect of Total Size of Lesions in Multifocal/Multicentric Breast Cancer on Survival.
     Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30449.
     PubMed     Text format     Abstract available
     
     
     
209. HOU Y, Nitta H, Wei L, Banks PM, et al
     Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy.
     Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30604.
     PubMed     Text format     Abstract available
     
     
     
210. RAGHAVENDRA A, Sinha AK, Valle J, Shen Y, et al
     Determinants of Weight Gain During Adjuvant Endocrine Therapy and Association of Such Weight Gain With Recurrence in Long-term Breast Cancer Survivors.
     Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30621.
     PubMed     Text format     Abstract available
     
     
     
211. FIGUEIREDO FWDS, Adami F
     Income Inequality and Mortality Owing to Breast Cancer: Evidence From Brazil.
     Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30526.
     PubMed     Text format     Abstract available
     
     
     
212. WADASADAWALA T, Lewis S, Parmar V, Budrukkar A, et al
     Bilateral Breast Cancer After Multimodality Treatment: A Report of Clinical Outcomes in an Asian Population.
     Clin Breast Cancer. 2017 Nov 9. pii: S1526-8209(17)30383.
     PubMed     Text format     Abstract available
     
     
     
213. FISCHER A, Ziogas A, Anton-Culver H
     Negative Valence Life Events Promote Breast Cancer Development.
     Clin Breast Cancer. 2017 Nov 1. pii: S1526-8209(16)30501.
     PubMed     Text format     Abstract available
     
     
     October 2017
214. MCREE AJ, Marcom PK, Moore DT, Zamboni WC, et al
     A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer.
     Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30313.
     PubMed     Text format     Abstract available
     
     
     
215. MCVEIGH TP, Wiggins J, Ward S, Kemp Z, et al
     Successful Repatriation of Breast Cancer Surveillance for High-Risk Women to the UK National Health Service Breast Screening Programme.
     Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30489.
     PubMed     Text format     Abstract available
     
     
     
216. PROCHOWSKI IAMURRI A, Ponziani M, Macchini M, Fogante M, et al
     Evaluation of Multifocality and Multicentricity With Breast Magnetic Resonance Imaging in Each Breast Cancer Subtype.
     Clin Breast Cancer. 2017 Oct 28. pii: S1526-8209(17)30164.
     PubMed     Text format     Abstract available
     
     
     
217. SALOUSTROS E, Nikolaou M, Kalbakis K, Polyzos A, et al
     Weekly Paclitaxel and Carboplatin Plus Bevacizumab as First-Line Treatment of Metastatic Triple-Negative Breast Cancer. A Multicenter Phase II Trial by the Hellenic Oncology Research Group.
     Clin Breast Cancer. 2017 Oct 24. pii: S1526-8209(17)30153.
     PubMed     Text format     Abstract available
     
     
     
218. HARDEFELDT PJ, Penninkilampi R, Edirimanne S, Eslick GD, et al
     Physical Activity and Weight Loss Reduce the Risk of Breast Cancer: A Meta-analysis of 139 Prospective and Retrospective Studies.
     Clin Breast Cancer. 2017 Oct 17. pii: S1526-8209(16)30429.
     PubMed     Text format     Abstract available
     
     
     
219. KUROSKY SK, Mitra D, Zanotti G, Kaye JA, et al
     Treatment Patterns and Outcomes of Patients With Metastatic ER(+)/HER-2(-) Breast Cancer: A Multicountry Retrospective Medical Record Review.
     Clin Breast Cancer. 2017 Oct 14. pii: S1526-8209(17)30060.
     PubMed     Text format     Abstract available
     
     
     
220. CHANG AE, Wu QV, Jenkins IC, Specht JM, et al
     Phase I/II Trial of Combined Pegylated Liposomal Doxorubicin and Cyclophosphamide in Metastatic Breast Cancer.
     Clin Breast Cancer. 2017 Oct 9. pii: S1526-8209(17)30280.
     PubMed     Text format     Abstract available
     
     
     
221. JANDIAL R, Hoshide R, Waters JD, Somlo G, et al
     Operative and Therapeutic Advancements in Breast Cancer Metastases to the Brain.
     Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30417.
     PubMed     Text format     Abstract available
     
     
     
222. HIEKEN TJ, Murphy BL, Boughey JC, Degnim AC, et al
     Influence of Biologic Subtype of Inflammatory Breast Cancer on Response to Neoadjuvant Therapy and Cancer Outcomes.
     Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30370.
     PubMed     Text format     Abstract available
     
     
     
223. RAISS H, Peron J, Tartas S, Trillet-Lenoir V, et al
     Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.
     Clin Breast Cancer. 2017 Oct 7. pii: S1526-8209(17)30072.
     PubMed     Text format    
     
     
     
224. HAYASHI N, Takahashi Y, Matsuda N, Tsunoda H, et al
     The Prognostic Effect of Changes in Tumor Stage and Nodal Status After Neoadjuvant Chemotherapy in Each Primary Breast Cancer Subtype.
     Clin Breast Cancer. 2017 Oct 3. pii: S1526-8209(17)30319.
     PubMed     Text format     Abstract available
     
     
     September 2017
225. HOUSSAMI N
     Evidence on Synthesized Two-dimensional Mammography Versus Digital Mammography When Using Tomosynthesis (Three-dimensional Mammography) for Population Breast Cancer Screening.
     Clin Breast Cancer. 2017 Sep 28. pii: S1526-8209(17)30558.
     PubMed     Text format     Abstract available
     
     
     
226. HEGDE JV, Wang X, Attai DJ, DiNome ML, et al
     Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
     Clin Breast Cancer. 2017 Sep 27. pii: S1526-8209(17)30512.
     PubMed     Text format     Abstract available
     
     
     
227. ITO T, Oura S, Nagamine S, Takahashi M, et al
     Radiofrequency Ablation of Breast Cancer: A Retrospective Study.
     Clin Breast Cancer. 2017 Sep 25. pii: S1526-8209(17)30241.
     PubMed     Text format     Abstract available
     
     
     
228. LEAL AD, Van Houten H, Sangaralingham L, Freedman RA, et al
     Breast Cancer Survivorship Care Variations Between Adjuvant Chemotherapy Regimens.
     Clin Breast Cancer. 2017 Sep 22. pii: S1526-8209(17)30422.
     PubMed     Text format     Abstract available
     
     
     
229. AKIMOTO E, Kadoya T, Kajitani K, Emi A, et al
     Role of 18F-PET/CT in Predicting Prognosis of Patients With Breast Cancer After Neoadjuvant Chemotherapy.
     Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30037.
     PubMed     Text format     Abstract available
     
     
     
230. WU J, Wang S, Liu F, Li S, et al
     Single Nucleotide Polymorphisms in the Acylphosphatase 2 Gene and The SNP-SNP Interactions on the Risk of Breast Cancer in Chinese Han Women.
     Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30157.
     PubMed     Text format     Abstract available
     
     
     
231. DIANATINASAB M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, et al
     Socioeconomic Factors, Health Behavior, and Late-Stage Diagnosis of Breast Cancer: Considering the Impact of Delay in Diagnosis.
     Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30358.
     PubMed     Text format     Abstract available
     
     
     
232. MANN JM, Wu X, Christos P, Nagar H, et al
     The State of Surgical Axillary Management and Adjuvant Radiotherapy for Early-stage Invasive Breast Cancer in the Modern Era.
     Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30461.
     PubMed     Text format     Abstract available
     
     
     
233. SAFRA T, Kaufman B, Kadouri L, Efrat Ben-Baruch N, et al
     Everolimus Plus Letrozole for Treatment of Patients With HR+, HER2- Advanced Breast Cancer Progressing on Endocrine Therapy: An Open-label, Phase II Trial.
     Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(17)30180.
     PubMed     Text format     Abstract available
     
     
     
234. SPINELLI VARELLA MA, Teixeira da Cruz J, Rauber A, Varella IS, et al
     Role of BI-RADS Ultrasound Subcategories 4A to 4C in Predicting Breast Cancer.
     Clin Breast Cancer. 2017 Sep 19. pii: S1526-8209(16)30505.
     PubMed     Text format     Abstract available
     
     
     
235. OBERGUGGENBERGER A, Meraner V, Sztankay M, Hilbert A, et al
     Health Behavior and Quality of Life Outcome in Breast Cancer Survivors: Prevalence Rates and Predictors.
     Clin Breast Cancer. 2017 Sep 18. pii: S1526-8209(17)30454.
     PubMed     Text format     Abstract available
     
     
     
236. FERNANDEZ-GONZALEZ S, Falo C, Pla MJ, Pernas S, et al
     The Shift From Sentinel Lymph Node Biopsy Performed Either Before or After Neoadjuvant Systemic Therapy in the Clinical Negative Nodes of Breast Cancer Patients. Results, and the Advantages and Disadvantages of Both Procedures.
     Clin Breast Cancer. 2017 Sep 4. pii: S1526-8209(17)30565.
     PubMed     Text format     Abstract available
     
     
     
237. ANAMPA J, Chen A, Wright J, Patel M, et al
     Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer.
     Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(17)30468.
     PubMed     Text format     Abstract available
     
     
     
238. ROGOZ B, Houze de l'Aulnoit A, Duhamel A, Houze de l'Aulnoit D, et al
     Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.
     Clin Breast Cancer. 2017 Sep 1. pii: S1526-8209(16)30427.
     PubMed     Text format     Abstract available
     
     
     August 2017
239. CHAMP CE, Ohri N, Klement RJ, Cantor M, et al
     Assessing Changes in the Activity Levels of Breast Cancer Patients During Radiation Therapy.
     Clin Breast Cancer. 2017 Aug 24. pii: S1526-8209(17)30285.
     PubMed     Text format     Abstract available
     
     
     
240. CHAO YL, Anders CK
     TYMS Gene Polymorphisms in Breast Cancer Patients Receiving 5-Fluorouracil-Based Chemotherapy.
     Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30369.
     PubMed     Text format    
     
     
     
241. WANG Y, Brodsky AS, Xiong J, Lopresti ML, et al
     Stromal Clusterin Expression Predicts Therapeutic Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer.
     Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30349.
     PubMed     Text format     Abstract available
     
     
     
242. CID S, Eiro N, Fernandez B, Sanchez R, et al
     Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
     Clin Breast Cancer. 2017 Aug 19. pii: S1526-8209(17)30189.
     PubMed     Text format     Abstract available
     
     
     
243. CHOI WJ, Kim WK, Shin HJ, Cha JH, et al
     Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
     Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30058.
     PubMed     Text format     Abstract available
     
     
     
244. AZIM HA, Abdel-Malek R, Kassem L
     Predicting Brain Metastasis in Breast Cancer Patients: Stage Versus Biology.
     Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30235.
     PubMed     Text format     Abstract available
     
     
     
245. KOOL M, Bastiaannet E, Van de Velde CJH, Marang-van de Mheen PJ, et al
     Reliability of Self-reported Treatment Data by Patients With Breast Cancer Compared With Medical Record Data.
     Clin Breast Cancer. 2017 Aug 18. pii: S1526-8209(17)30212.
     PubMed     Text format     Abstract available
     
     
     
246. DONG H, Huang Y, Song F, Dai H, et al
     Improved Performance of Adjunctive Ultrasonography After Mammography Screening for Breast Cancer Among Chinese Females.
     Clin Breast Cancer. 2017 Aug 15. pii: S1526-8209(17)30321.
     PubMed     Text format     Abstract available
     
     
     
247. CHEN W, Huang Y, Lewis GD, Szeja SS, et al
     Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
     Clin Breast Cancer. 2017 Aug 10. pii: S1526-8209(17)30185.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: